.png)
You've raised the capital. Now it's time to prove the commercial model, accelerate growth and build a business that delivers on it's potential.
The opportunity is real.
The time to execute is now.
Women's health is entering its Era of Scale backed by capital, driven by innovation and fueled by demand. The companies that will be those that combine product innovation with commercial excellence.
$1.55B
invested in women's health in 2025, a 41% increase from 2024.*
Strong and growing investor confidence in the category.
10
rounds of $50M+ in 2025 - double the number in 2024**.
Momentum is building. Execution separates leaders from the rest.
85
ventured-backed women's health companies in 2025. **
More innovation. More capital. More competition.
Sources: W Group 2025 Women's Health Investment Report; Bioxconomy, 2025
The right commercial decisions now will determine your trajectory and your next milestone.
Where should we place our bets for the greatest commercial impact?
Who are our best buyers and which markets deserve our investment?
How do we turn our positioning into pipeline and revenue?
What's working, what isn't and where should we adjust?
What commercial capabilities should we build now?
What milestones will move us to the next raise?
Bostonia gives founders access to senior commercialization experience at the moments when a few critical decisions can materially change the trajectory of the company.
FOCUS INVESTMENTS
ACCELERATE TRACTION
PROVE THE MODEL
BUILD FOR SCALE
Flexible engagement. Senior expertise. Build to grow with you.
STRATEGIC PROJECT
Tackle a critical commercial challenge or decision.
COMMERCIAL ROADMAP
Align on priorities, market strategy and go-to-market plan that drives results.
FRACTIONAL ADVISORY
Ongoing senior guidance to execute, optimize and adapt as you scale.
EMBEDDED SUPPORT
Hands-on partnership to lead initiatives and build what's needed.
